Key Takeaways
- • Germany's family office sector comprises an estimated 400 single family offices concentrated in five major financial hubs (Munich, Hamburg, Frankfurt, Berlin, Düsseldorf), collectively deploying capital across private equity, real estate, infrastructure, venture capital, and private credit.
- • Athos KG, the Strüngmann family office based in Munich, leads the ranking with $30 billion in AUM, built on proceeds from the 2005 sale of generic pharmaceutical company Hexal to Novartis for approximately €5.6 billion.
- • German family offices operate in a favorable institutional environment with corporate pension funding at a record 93% coverage ratio (January 2026), positioning them as some of Europe's most active and decisive capital allocators with faster decision-making cycles than traditional pension funds.
- • Dakota Marketplace tracks 200 family office accounts across Germany with 428 verified contacts, indicating a highly concentrated but well-mapped investor base for fundraisers and deal sourcing professionals.
- • Family offices in Germany demonstrate a strong scientific and sector-focused investment thesis: Athos KG specifically concentrates on healthcare, life sciences, and deep technology, including stakes in BioNTech and early-stage biotech and AI-enabled drug discovery platforms.
Summary
Germany's family office sector has solidified its position as one of Europe's most dynamic pools of alternative capital, supported by decades of Mittelstand wealth creation, pharmaceutical and technology exits, and multi-generational industrial families. The country is home to approximately 400 single family offices, with concentrated geographic presence in Munich, Hamburg, Frankfurt, Berlin, and Düsseldorf. These offices collectively manage substantial capital across diversified asset classes including private equity, real estate, infrastructure, venture capital, and private credit.
The competitive positioning of German family offices has strengthened relative to traditional institutional investors. With German corporate pension funding reaching a record 93% coverage ratio as of January 2026 (per Mercer data), institutional pension allocators have become increasingly selective in deployment strategies. This dynamic has elevated the relative importance of family offices as decisive market participants. Family offices typically move faster than pension funds, maintain flexibility to co-invest directly alongside sponsors, and allocate across the full capital structure—characteristics that appeal to fund managers and operating companies seeking reliable, long-duration capital.
Athos KG, the single family office of the Strüngmann family, anchors the German family office landscape with $30 billion in assets under management. The office was capitalized through the 2005 sale of Hexal, a generic pharmaceutical company, to Novartis for approximately €5.6 billion—a transaction that created one of the largest pools of private capital in German healthcare and life sciences history. Since then, Athos has deployed capital with a consistent scientific thesis centered on long-term investment in companies building the next wave of healthcare, biotech, and technology innovation. The office holds stakes in BioNTech, a co-founder of the Pfizer/BioNTech COVID vaccine platform, and continues to back early and growth-stage biotech, genomics, and AI-enabled drug discovery enterprises.
The German family office market benefits from robust data infrastructure for investor identification and outreach. Dakota Marketplace currently tracks 200 family office accounts across Germany with 428 verified contact relationships, providing a transparent foundation for fundraisers and deal professionals seeking to access this capital base. The combination of substantial AUM, sector focus, geographic concentration, and documented decision-maker networks positions German family offices as priority targets for healthcare, technology, and infrastructure fund strategies seeking European exposure.
The competitive positioning of German family offices has strengthened relative to traditional institutional investors. With German corporate pension funding reaching a record 93% coverage ratio as of January 2026 (per Mercer data), institutional pension allocators have become increasingly selective in deployment strategies. This dynamic has elevated the relative importance of family offices as decisive market participants. Family offices typically move faster than pension funds, maintain flexibility to co-invest directly alongside sponsors, and allocate across the full capital structure—characteristics that appeal to fund managers and operating companies seeking reliable, long-duration capital.
Athos KG, the single family office of the Strüngmann family, anchors the German family office landscape with $30 billion in assets under management. The office was capitalized through the 2005 sale of Hexal, a generic pharmaceutical company, to Novartis for approximately €5.6 billion—a transaction that created one of the largest pools of private capital in German healthcare and life sciences history. Since then, Athos has deployed capital with a consistent scientific thesis centered on long-term investment in companies building the next wave of healthcare, biotech, and technology innovation. The office holds stakes in BioNTech, a co-founder of the Pfizer/BioNTech COVID vaccine platform, and continues to back early and growth-stage biotech, genomics, and AI-enabled drug discovery enterprises.
The German family office market benefits from robust data infrastructure for investor identification and outreach. Dakota Marketplace currently tracks 200 family office accounts across Germany with 428 verified contact relationships, providing a transparent foundation for fundraisers and deal professionals seeking to access this capital base. The combination of substantial AUM, sector focus, geographic concentration, and documented decision-maker networks positions German family offices as priority targets for healthcare, technology, and infrastructure fund strategies seeking European exposure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.